Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds

Surgery

Volumn 127, Issue 6, 2000, Pages 687-695

  Bitar, Milad S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; INSULIN; MESSENGER RNA; MIFEPRISTONE; PLACEBO; POLYVINYL ALCOHOL SPONGE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAINLESS STEEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERCORTISOLISM; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; WOUND HEALING IMPAIRMENT;

EID: 0034047277     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.105869     Document Type: Article

References (65)

1. 1. Chittenden SJ, Skhami SK. Microangiopathy in diabetes mellitus: causes, prevention and treatment. Diabetes Res 1991;17:105-14.
2. 2. Jones EW, Peacock I, McLain S, et al. A clinico-pathological study of diabetic foot ulcers. Diabet Med 1987;4:475-9.
3. 3. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:513-21.
4. 4. Goodson WH, Hunt TK. Studies of wound healing in experimental diabetes. J Surg Res 1977;22:221-7.
5. 5. Prokash MK, Sharma LK. Studies in wound healing in experimental diabetes. Int Surg 1974;59:25-8.
6. 6. Goodson WH, Hunt TK. Wound healing and the diabetic patients. Surg Gynecol Obstet 1979;149:600-8.
7. 7. Yue DK, McLennon S, Marsh M, et al. Effects of experimental diabetes uremia and malnutrition on wound healing. Diabetes 1987;36:295-9.
8. 8. Fahey TJ, Sadaty A, Jones WG, et al. Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991;50:308-18.
9. 9. Bitar MS, Farook T, Wahid S, et al. Glucocorticoid-dependent impairment of wound healing in experimental diabetes: amelioration by adrenalectomy and RU 486. J Surg Res 1999;82:234-43.
10. 10. Bitar MS. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am J Pathol 1998;152:547-54.
11. 11. McMurray JF. Wound healing with diabetes mellitus. Surg Clin North Am 1984;4:769-77.
12. 12. Bashey RL, Perlish JS, Fleischmayer R. Stimulation of collagen synthesis in embryonic chick skin by insulin. Connect Tissue Res 1972;1:189-93.
13. 13. Mikkonen L, Sampiaho K, Kulonen E. Effect of thyroid hormones, somatotrophin, insulin and corticosteroids on synthesis of collagen in granulation issue both in vivo and in vitro. Acta Endocrinol 1966;51:23-31.
14. 14. Rosenthal SP. Acceleration of primary wound healing by insulin. Arch Surg 1968;96:53-5.
15. 15. Andreassen TT, Oxlund H. The influence of experimental diabetes and insulin treatment on the biochemical properties of rat skin incisional wounds. Acta Chir Scand 1987; 153:405-9.
16. 16. Bagdade JD, Neilson KL, Bulger RJ. Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 1972;263:451-6.
17. 17. Sandberg N. Time relationship between administration of cortisone and wound healing in rats. Acta Chir Scand 1964; 127:446-55.
18. 18. Goforth P, Gudes CT. Effects of steroids on wound healing: a review of the literature. J Foot Surg 1980;19:22-8.
19. 19. McNamara JJ, Lamborn PJ, Mills DM, et al. Effect of short term pharmacological doses of adrenocorticosteroid therapy on wound healing. Ann Surg 1968;167:324-8.
20. 20. Hunt TK, Ehrlich HP, Garcia JA, et al. Effect of vitamin A on reversing the inhibitory effect of corticosterone on healing of open wounds in animals and men. Ann Surg 1969;170:633-41.
21. 21. D'Ercole AJ, Stiles JAD, Underwood LE. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci U S A 1984;81:935-9.
22. 22. Lowe WL, Roberts LCT Jr, Lasky SR, et al. Differential expression of alternative in untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc Natl Acad Sci U S A 1987;84:8946-50.
23. 23. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci U S A 1986;83:9343-7.
24. 24. Shimaski S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGF BP 1,2,3,4,5,6). Prog Growth Factor Res 1991;3:343-6.
25. 25. LeRoith D, Clemmons D, Nissley P, et al. Insulin-like growth factor I in health and disease. Ann Intern Med 1992;116: 854-62.
26. 26. LeRoith D. Insulin-like growth factors. New Engl J Med 1997;336:633-40.
27. 3 in wound healing. In: Spencer EM, editor. Modern concepts of insulin-like growth factors. New York: Elsevier; 1991. p. 185-92.
28. 28. Gartener MH, Benson JD, Caldwell MD. Insulin-like growth factor I and II expression in the healing wounds. J Surg Res 1992;52:389-4.
29. 29. Steenfos HH, Janssen JO. Gene expression of insulin-like growth factor I and receptor during wound healing in rats. Eur J Surg 1992;158:327-31.
30. 30. Hakim FS, Shetty S, Sidway A, et al. Increased specific binding of insulin-like growth factor I in healing cutaneous wounds. Wound Repair Regen 1993;3:492-9.
31. 31. Bitar MS, Labbad ZN. Transforming growth factor beta and insulin-like growth factor I in relation to diabetes-induced impairment of wound healing. J Surg Res 1996;61:113-9.
32. 32. Arner P, Sjoberg S, Gjotterberg M, et al. Circulating insulin-like growth factor I in type I (insulin-dependent) diabetic patients with retinopathy. Diabetologia 1989;32:753-8.
33. 33. Bitar MS. Insulin-like growth factor I reverses diabetes-induced wound healing impairment in rats. Horm Metab Res 1997;29:383-6.
34. 34. Knox WF, Auerback VH. The hormonal control of tryptophan peroxidase in the rat. J Biol Chem 1955;214:307-13.
35. 35. Gjerd H, Morland J, Olsen H. The antiglucocorticoid RU 486 inhibits the ethanol-induced increase of tryptophan oxygenase. J Steroid Biochem 1985;23:1091-2.
36. 36. Bertagan X, Bertagan C, Luton JP, et al. The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 1984;59:25-8.
37. 37. Jung-Testas I, Baulieu EE. Inhibition of glucocorticoid action in cultured L-929 mouse fibroblasts by RU 486, a new antiglucocorticoid high affinity for the glucocorticoid receptor. Exp Cell 1983;147:177-82.
38. 38. Moguilewsky M, Philibert D. RU 38486: potent antiglucocorticoid activities correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J Steroid Biochem 1984;20:271-6.
39. 39. Chrousos GP, Laue L, Nieman LK et al. Glucocorticoids and glucocorticoid antagonists: lessons from RU 486. Kidney Int 1988;34(26 Suppl):S18-S23.
40. 40. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
41. 41. Grulich-Henn J, Spiess S, Heinrich U, et al. Ligand blot analysis of insulin-like growth factor binding proteins using biotinylated insulin-like growth factor I. Horm Res 1998;49:1-7.
42. 42. Laemmli UK. Cleavage of structural proteins during assembly of the head. Nature 1970;227:680-5.
43. 43. Hossenlopp P, Seurin D, Segovia-Quinson B, et al. Analysis of serum IGF-BPs using Western-blotting: use of the method for titration of the binding proteins and competitive-binding studies. Anal Biochem 1986;154:138-43.
44. 44. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagents. J Biol Chem 1951; 193:265-75.
45. 45. Feteris WA. A serum glucose method without protein precipitation. Am J Med Technol 1965;31:917-21.
46. 46. Cianfarani S, Holly JMP. Somatomedin-binding proteins: what role do they play in the growth process. Eur J Pediatr 1989;149:76-9.
47. 47. Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg 1973;177:222-7.
48. 48. Diegelmann RF, Lindblad WJ, Cohen IK. A subcutaneous implant for wound healing studies in humans. J Surg Res 1986;40:229-34.
49. 49. Thomas PK. Diabetic neuropathy: human and experimental. Drugs 1986;32:36-42.
50. 50. Yagihashi S. Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 1995;11:193-225.
51. 51. Brown MR, Dyck PJ, McClearn GE, et al. Central and peripheral nervous system complications. Diabetes (Suppl 1) 1982;31:65-70.
52. 52. Wuarin L, Guertin DM, Ishii DN. Early reduction in insulin-like growth factor gene expression in diabetic nerve. Exp Neurol 1994;130:106-14.
53. 53. Bitar MS, Pilcher CWT. Attenuation of IGF-I antinociceptive action and a reduction in spinal cord gene expression of its receptor in experimental diabetes. Pain 1998;75:69-74.
54. 54. Bitar MS, Pilcher CWT, Khan I, et al. Diabetes-induced suppression of IGF-I and its receptor mRNA levels in rat superior cervical ganglia. Diabetes Res Clin Pract 1997;38:73-80.
55. 55. Leaman DW, Simmen FA, Ramsay TG, et al. Insulin-like growth factor I and II messenger RNA expression in muscle, heart, and liver of streptozotocin-diabetic swine. Endocrinology 1990;126:2850-7.
56. 56. Pao CI, Farmer PK, Begovic S, et al. Regulation of insulin-like growth factor-I (IGF-I) and IGF binding protein I gene transcription by hormones and provisions of amino acids in rat hepatocytes. Mol Endocrinol 1993;7:1561-8.
57. 57. Unterman TG, Phillips LS. Glucocorticoid effect on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 1985;61:618-28.
58. 58. Adamo M, Werner H, Farnsworth W, et al. Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture. Endocrinology 1988;123:2565-70.
59. 59. Luo J, Murphy LJ. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I, mRNA abundance in the intact rat. Endocrinology 1989;125:165-71.
60. 60. Canalis E, Centrella M, Burch W, et al. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone culture. J Clin Invest 1989;83:60-5.
61. 3 modulation of insulin-like growth factor binding proteins in rat osteoblast-like cell cultures. Endocrinology 1991;128:73-80.
62. 62. Swolin D, Brantsing C, Matejka G, et al. Corusol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol 1996;149:397-403.
63. 63. Cameron OG, Thomas B, Tiongeo D, et al. Hypercortisolisms in diabetes mellitus. Diabetes Care 1987;10:662-4
64. 64. Roy M, Collier B, Roy A. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychol Res 1990;31:31-7.
65. 65. Suh DY, Hunt TK, Spencer EM. Insulin-like growth factor-1 reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 1992;131:2399-403.